From: Concurrent vs. sequential chemoradiotherapy: a survival boost for lung cancer patients
Groups | CA125 (U/ml) | SCC-Ag (ng/mL) | CYFRA21-1 (ng/mL) | |||
---|---|---|---|---|---|---|
 | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment |
The control group (n = 78) | 260.23 ± 9.58 | 85.56 ± 4.56* | 4.56 ± 0.45 | 1.96 ± 0.20* | 25.65 ± 5.23 | 21.56 ± 4.66* |
The observation group (n = 80) | 261.23 ± 9.56 | 49.56 ± 5.56* | 4.49 ± 0.42 | 1.60 ± 0.14* | 24.98 ± 5.65 | 16.85 ± 4.56* |
t value | 0.657 | 44.439 | 1.011 | 13.135 | 0.773 | 6.421 |
P value | 0.512 | < 0.001 | 0.314 | < 0.001 | 0.441 | < 0.001 |